Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: TENNOR THERAP-B(06872) the EBIT is -35.43 M (-47.17%);the EPS is -0.858 (+22.52%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.04B47.17%
----
----
EPS
-0.857922.52%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf